🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to demonstrate the non-inferior efficacy of TA...
Status
Completed
Location
The First Affiliated Hospital of Anhui Medical University
Start Date
2017-04-17
Trial ID
NCT03050307
Treatments Being Tested
The primary purpose of this study was to evaluate the safety, tolerability,...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT02141698
Treatments Being Tested
The purpose of this study was to evaluate the efficacy and safety of oral T...
Status
Completed
Location
Multiple Locations
Start Date
2016-11-15
Trial ID
NCT02954848
Treatments Being Tested
The purpose of this study was to evaluate the safety and pharmacokinetics o...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT02123953
Treatments Being Tested
The purpose of this study is to determine the effect of vonoprazan compared...
Status
Completed
Location
Medif
Start Date
2016-07-14
Trial ID
NCT02743949
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of TAK-438, once dail...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01452750
The purpose of this study is to determine the efficacy of TAK-438, once dai...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01452698
Treatments Being Tested
The purpose of this study is to investigate the efficacy of TAK-438, once d...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01452711
Treatments Being Tested
The purpose of this study is to confirm the efficacy of TAK-438, once daily...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01459367
Treatments Being Tested
This is a comparative study of vonoprazan (TAK-438) (10 mg or 20 mg) in par...
Status
Completed
Location
Beijing Chao Yang Hospital
Start Date
2015-04-01
Trial ID
NCT02388737
Treatments Being Tested